Alterity Therapeutics (ATHE) Free Cash Flow (2009 - 2020)
Alterity Therapeutics (ATHE) posted quarterly Free Cash Flow of -$6.2 million for Q2 2020, up 36.76% year-over-year from -$4.5 million in Q3 2019, and down 450.94% quarter-over-quarter from $1.8 million in Q4 2019.
Alterity Therapeutics (ATHE) Free Cash Flow (2009 - 2020) Analysis & Trends
Alterity Therapeutics' Free Cash Flow history runs 9 years deep, the most recent figure standing at -$6.2 million for Q2 2020.
- In Q2 2020, Free Cash Flow rose 36.76% year-over-year to -$6.2 million; the TTM figure through Dec 2021 stood at -$6.2 million (up 56.45% YoY), while the FY2025 annual figure was -$7.3 million, up 11.76% from the prior year.
- Free Cash Flow for Q2 2020 stood at -$6.2 million, down from $1.8 million in the prior quarter.
- The five-year high for Free Cash Flow was $1.8 million in Q4 2019, with the low at -$9.8 million in Q2 2019.
- The 5-year median for Free Cash Flow is -$4.4 million (2017), against an average of -$3.4 million.
- Peak annual rise in Free Cash Flow reached 134.01% in 2019, while the deepest fall reached 20575.33% in 2019.
- Alterity Therapeutics' Free Cash Flow stood at -$449190.3 in 2016, then tumbled by 100.19% to -$899256.0 in 2017, then slumped by 475.87% to -$5.2 million in 2018, then jumped by 134.01% to $1.8 million in 2019, then sank by 450.94% to -$6.2 million in 2020.
- Business Quant data shows ATHE's Free Cash Flow at -$6.2 million in Q2 2020, $1.8 million in Q4 2019, and -$9.8 million in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -563.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 437.80 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 292.04 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 433.84 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -95.09 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 477.44 Mn |
| 10 | Alterity Therapeutics | 48.56 Mn | 16.26 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -6.18 Mn |
| Jun 30, 2020 | -6.18 Mn |
| Dec 31, 2019 | 1.76 Mn |
| Dec 31, 2019 | 1.76 Mn |
| Jun 30, 2019 | -9.77 Mn |
| Jun 30, 2019 | -9.77 Mn |
| Dec 31, 2018 | -5.18 Mn |
| Dec 31, 2018 | -5.18 Mn |
| Jun 30, 2018 | -47,278.38 |
| Jun 30, 2018 | -47,278.38 |
| Dec 31, 2017 | -899,256.01 |
| Dec 31, 2017 | -899,256.01 |
| Jun 30, 2017 | -4.41 Mn |
| Jun 30, 2017 | -4.41 Mn |
| Dec 31, 2016 | -449,190.35 |
| Dec 31, 2016 | -449,190.35 |
| Jun 30, 2016 | -5.54 Mn |
| Jun 30, 2016 | -5.54 Mn |
| Jun 30, 2012 | -6,916.69 Bn |
| Jun 30, 2012 | -6,916.69 Bn |